Skip to Content

NeueHealth Inc NEUE

Morningstar Rating
$6.11 −0.22 (3.54%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NEUE is trading at a 50% discount.
Price
$6.31
Fair Value
$96.68
Uncertainty
Extreme
1-Star Price
$33.38
5-Star Price
$6.96
Economic Moat
Zfwr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NEUE is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$6.33
Day Range
$5.956.48
52-Week Range
$4.9437.20
Bid/Ask
$5.40 / $6.97
Market Cap
$50.25 Mil
Volume/Avg
15,815 / 16,670

Key Statistics

Price/Earnings (Normalized)
0.36
Price/Sales
0.04
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.
Sector
Healthcare
Industry
Healthcare Plans
Stock Style Box
Small Growth
Total Number of Employees
1,252

Comparables

Valuation

Metric
NEUE
ASTH
PIII
Price/Earnings (Normalized)
0.3623.610.06
Price/Book Value
2.800.43
Price/Sales
0.041.240.12
Price/Cash Flow
18.82
Price/Earnings
NEUE
ASTH
PIII

Financial Strength

Metric
NEUE
ASTH
PIII
Quick Ratio
0.182.030.53
Current Ratio
0.782.110.55
Interest Coverage
−15.475.70−10.49
Quick Ratio
NEUE
ASTH
PIII

Profitability

Metric
NEUE
ASTH
PIII
Return on Assets (Normalized)
2.05%7.43%−20.64%
Return on Equity (Normalized)
12.90%−461.86%
Return on Invested Capital (Normalized)
13.41%9.45%−29.07%
Return on Assets
NEUE
ASTH
PIII
See how this stock stacks up to its competitors with Morningstar Investor

Healthcare Plans Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
UNH
UnitedHealth Group IncDnrzzdrgnXslppd$455.8 Bil
ELV
Elevance Health IncVqfjbmbsjCshjrm$124.9 Bil
CI
The Cigna GroupWxrqrrnzlMjlcfqr$100.6 Bil
CVS
CVS Health CorpWxtcmsvxdRnhqsdq$84.7 Bil
CNC
Centene CorpLtgcxmlssBlqmlc$39.6 Bil
HUM
Humana IncXpwlncqZlddxs$37.5 Bil
MOH
Molina Healthcare IncGvnqkq$20.0 Bil
OSCR
Oscar Health Inc Class AVkmg$4.0 Bil
ALHC
Alignment Healthcare IncJzhj$984.6 Mil
CLOV
Clover Health Investments Corp Ordinary Shares - Class ANcfm$336.8 Mil

Sponsor Center